부인과영역에서의 Vibramycin Precon PT-122M의 임상효과

Abstract

The clinical efficacy of Vibramycin Precon PT-122 M on various infections in OB-GYN was studied. The aims of this study are determination of local and systemic tolerance of PT-122M intravenous administration and also determination of side effect as well as the clinical efficacy. 1. The over-all efficacy of this intravenous formulation of Vibramycin was good and satisfactory in 92% of patients studied. 2. Most of patients(82%) were considered to be tolerated to this intravenous Vibramycin. 3. Several side effects were observed. but in most patients the disease process and treatment were not influenced by side effects, except six patients in whom the treatment had to be discontinued.